Nektar Therapeutics (NKTR)
(Real Time Quote from BATS)
$1.28 USD
+0.05 (4.07%)
Updated Jul 10, 2024 11:22 AM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.21 |
EPS Last Quarter | -0.18 |
Last EPS Surprise | 14.29% |
ABR | 3.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.84 |
Next Year | -0.72 |
EPS (TTM) | -0.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 17.24M | 16.84M | 73.48M | 63.02M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 20.93M | 21.88M | 85.43M | 83.04M |
Low Estimate | 5.20M | 5.20M | 37.70M | 22.90M |
Year ago Sales | 20.50M | 24.14M | 90.12M | 73.48M |
Year over Year Growth Est. | -15.91% | -30.25% | -18.46% | -14.23% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.21 | -0.22 | -0.84 | -0.72 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.22 | -0.22 | -0.89 | -0.94 |
High Estimate | -0.20 | -0.21 | -0.79 | -0.36 |
Low Estimate | -0.24 | -0.25 | -0.89 | -1.01 |
Year ago EPS | -0.27 | -0.19 | -1.45 | -0.84 |
Year over Year Growth Est. | 22.22% | -15.79% | 42.07% | 15.24% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.21 | -0.22 | -0.84 | -0.72 |
7 Days Ago | -0.21 | -0.22 | -0.84 | -0.72 |
30 Days Ago | -0.21 | -0.22 | -0.84 | -0.72 |
60 Days Ago | -0.21 | -0.21 | -0.93 | -0.77 |
90 Days Ago | -0.20 | -0.20 | -0.93 | -0.77 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.21 | -0.22 | -0.84 | -0.72 |
Zacks Consensus Estimate | -0.21 | -0.22 | -0.84 | -0.72 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.18 | -0.22 | -0.19 | -0.27 | NA |
Estimate | -0.21 | -0.20 | -0.18 | -0.30 | NA |
Difference | 0.03 | -0.02 | -0.01 | 0.03 | 0.01 |
Surprise | 14.29% | -10.00% | -5.56% | 10.00% | 2.18% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more